Adhesion molecule expression precedes brain damages of lupus-prone mice and correlates with kidney pathology

Journal of Neuroimmunology

Volumn 252, Issue 1-2, 2012, Pages 24-32

  Stielke, Sebastian ^a   Keilhoff, Gerburg ^a   Kirches, Elmar ^a   Mertens, Peter R ^a   Neumann, Klaus Hinrich ^a   Tsokos, George C ^b   Mawrin, Christian ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Brain; Cell adhesion molecules; Lupus erythematosus

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BLOOD VESSEL WALL; BRAIN DAMAGE; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; KIDNEY PARENCHYMA; MICROGLIA; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

ANIMALS; BRAIN; CELL ADHESION MOLECULES; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; LUPUS NEPHRITIS; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; REAL-TIME POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84867140009     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.07.011     Document Type: Article

References (52)

1. Abbott N.J., Mendonca L.L., Dolman D.E. The blood-brain barrier in systemic lupus erythematosus. Lupus 2003, 12:908-915.
2. Adams J., Kiss E., Arroyo A.B., Bonrouhi M., Sun Q., Li Z., Gretz N., Schnitger A., Zouboulis C.C., Wiesel M., Wagner J., Nelson P.J., Grone H.J. 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am. J. Pathol. 2005, 167:285-298.
3. Alcocer-Varela J., Aleman-Hoey D., Alarcon-Segovia D. Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers. Lupus 1992, 1:111-117.
4. Ballok D.A., Earls A.M., Krasnik C., Hoffman S.A., Sakic B. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice. J. Neuroimmunol. 2004, 152:83-97.
5. Ballok D.A., Woulfe J., Sur M., Cyr M., Sakic B. Hippocampal damage in mouse and human forms of systemic autoimmune disease. Hippocampus 2004, 14:649-661.
6. Belmont H.M., Buyon J., Giorno R., Abramson S. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum 1994, 37:376-383.
7. Bluestein H.G., Williams G.W., Steinberg A.D. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am. J. Med. 1981, 70:240-246.
8. Boswell J.M., Yui M.A., Burt D.W., Kelley V.E. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J. Immunol. 1988, 141:3050-3054.
9. Brey R.L., Amato A.A., Kagan-Hallet K., Rhine C.B., Stallworth C.L. Anti-intercellular adhesion molecule-1 (ICAM-1) antibody treatment prevents central and peripheral nervous system disease in autoimmune-prone mice. Lupus 1997, 6:645-651.
10. Brey R.L., Holliday S.L., Saklad A.R., Navarrete M.G., Hermosillo-Romo D., Stallworth C.L., Valdez C.R., Escalante A., del R.I., Gronseth G., Rhine C.B., Padilla P., McGlasson D. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002, 58:1214-1220.
11. Carbotte R.M., Denburg S.D., Denburg J.A. Prevalence of cognitive impairment in systemic lupus erythematosus. J. Nerv. Ment. Dis. 1986, 174:357-364.
12. Cohen P.L., Eisenberg R.A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 1991, 9:243-269.
13. Daniel L., Sichez H., Giorgi R., Dussol B., Figarella-Branger D., Pellissier J.F., Berland Y. Tubular lesions and tubular cell adhesion molecules for the prognosis of lupus nephritis. Kidney Int. 2001, 60:2215-2221.
14. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 2001, 7:1189-1193.
15. Elliott M.K., Jarmi T., Ruiz P., Xu Y., Holers V.M., Gilkeson G.S. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. Kidney Int. 2004, 65:129-138.
16. Faust T.W., Chang E.H., Kowal C., Berlin R., Gazaryan I.G., Bertini E., Zhang J., Sanchez-Guerrero J., Fragoso-Loyo H.E., Volpe B.T., Diamond B., Huerta P.T. Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:18569-18574.
17. Feng P.H., Cheah P.S., Lee Y.K. Mortality in systemic lupus erythematosus: a 10-year review. Br. Med. J. 1973, 4:772-774.
18. Gharavi A.E. Anticardiolipin syndrome: antiphospholipid syndrome. Clin. Med. 2001, 1:14-17.
19. Harari O.A., Marshall D., McHale J.F., Ahmed S., Haskard D.O. Limited endothelial E- and P-selectin expression in MRL/lpr lupus-prone mice. Rheumatology (Oxford) 2001, 40:889-895.
20. Hickey M.J., Bullard D.C., Issekutz A., James W.G. Leukocyte-endothelial cell interactions are enhanced in dermal postcapillary venules of MRL/fas(lpr) (lupus-prone) mice: roles of P- and E-selectin. J. Immunol. 2002, 168:4728-4736.
21. James W.G., Bullard D.C., Hickey M.J. Critical role of the alpha 4 integrin/VCAM-1 pathway in cerebral leukocyte trafficking in lupus-prone MRL/fas(lpr) mice. J. Immunol. 2003, 170:520-527.
22. Jung R.E., Segall J.M., Grazioplene R.G., Qualls C., Sibbitt W.L., Roldan C.A. Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus. PLoS One 2010, 5:e9302.
23. Kelley V.E., Roths J.B. Interaction of mutant lpr gene with background strain influences renal disease. Clin. Immunol. Immunopathol. 1985, 37:220-229.
24. Khamashta M.A., Harris E.N., Gharavi A.E., Derue G., Gil A., Vazquez J.J., Hughes G.R. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann. Rheum. Dis. 1988, 47:849-854.
25. Kowal C., Degiorgio L.A., Lee J.Y., Edgar M.A., Huerta P.T., Volpe B.T., Diamond B. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19854-19859.
26. Kuhn A., Sonntag M., Sunderkotter C., Lehmann P., Vestweber D., Ruzicka T. Upregulation of epidermal surface molecule expression in primary and ultraviolet-induced lesions of lupus erythematosus tumidus. Br. J. Dermatol. 2002, 146:801-809.
27. Lhotta K., Neumayer H.P., Joannidis M., Geissler D., Konig P. Renal expression of intercellular adhesion molecule-1 in different forms of glomerulonephritis. Clin. Sci. (Lond.) 1991, 81:477-481.
28. Liou H.H., Wang C.R., Chen C.J., Chen R.C., Chuang C.Y., Chiang I.P., Tsai M.C. Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients. Lupus 1996, 5:307-312.
29. Marshall D., Dangerfield J.P., Bhatia V.K., Larbi K.Y., Nourshargh S., Haskard D.O. MRL/lpr lupus-prone mice show exaggerated ICAM-1-dependent leucocyte adhesion and transendothelial migration in response to TNF-alpha. Rheumatology (Oxford) 2003, 42:929-934.
30. McHale J.F., Harari O.A., Marshall D., Haskard D.O. TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. J. Immunol. 1999, 163:3993-4000.
31. Nakatani K., Fujii H., Hasegawa H., Terada M., Arita N., Ito M.R., Ono M., Takahashi S., Saiga K., Yoshimoto S., Iwano M., Shiiki H., Saito Y., Nose M. Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus models. Kidney Int. 2004, 65:1290-1300.
32. Norman M.U., James W.G., Hickey M.J. Differential roles of ICAM-1 and VCAM-1 in leukocyte-endothelial cell interactions in skin and brain of MRL/faslpr mice. J. Leukoc. Biol. 2008, 84:68-76.
33. Perry D., Sang A., Yin Y., Zheng Y.Y., Morel L. Murine models of systemic lupus erythematosus. J. Biomed. Biotechnol. 2011, 2011:271694.
34. Reefman E., Kuiper H., Limburg P.C., Kallenberg C.G., Bijl M. Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients. Ann. Rheum. Dis. 2008, 67:11-18.
35. Sabry A., Sheashaa H., El-Husseini A., El-Dahshan K., Abdel-Rahim M., Elbasyouni S.R. Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis. Clin. Rheumatol. 2007, 26:1819-1823.
36. Sakic B., Kolb B., Whishaw I.Q., Gorny G., Szechtman H., Denburg J.A. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease?. J. Neuroimmunol. 2000, 111:93-101.
37. Scolding N.J., Joseph F.G. The neuropathology and pathogenesis of systemic lupus erythematosus. Neuropathol. Appl. Neurobiol. 2002, 28:173-189.
38. Sibbitt W.L., Brooks W.M., Kornfeld M., Hart B.L., Bankhurst A.D., Roldan C.A. Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin. Arthritis Rheum. 2009, 40:32-52.
39. Springer T.A. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 1995, 57:827-872.
40. Tomita M., Holman B.J., Santoro T.J. Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus. Neurosci. Lett. 2001, 302:129-132.
41. Tomita M., Holman B.J., Williams L.S., Pang K.C., Santoro T.J. Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus. J. Neurosci. Res. 2001, 64:26-33.
42. Trysberg E., Carlsten H., Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 2000, 9:498-503.
43. Tsokos G.C. Systemic lupus erythematosus. N. Engl. J. Med. 2011, 365:2110-2121.
44. Vogelgesang S.A., Heyes M.P., West S.G., Salazar A.M., Sfikakis P.P., Lipnick R.N., Klipple G.L., Tsokos G.C. Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations. J. Rheumatol. 1996, 23:850-855.
45. Wellicome S.M., Thornhill M.H., Pitzalis C., Thomas D.S., Lanchbury J.S., Panayi G.S., Haskard D.O. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J. Immunol. 1990, 144:2558-2565.
46. Wu J., Zhou T., Zhang J., He J., Gause W.C., Mountz J.D. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2344-2348.
47. Wu D.T., Woodman S.E., Weiss J.M., McManus C.M., D'Aversa T.G., Hesselgesser J., Major E.O., Nath A., Berman J.W. Mechanisms of leukocyte trafficking into the CNS. J. Neurovirol. 2000, 6(Suppl. 1):S82-S85.
48. Wuthrich R.P. Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int. 1992, 42:903-914.
49. Wuthrich R.P., Jevnikar A.M., Takei F., Glimcher L.H., Kelley V.E. Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. Am. J. Pathol. 1990, 136:441-450.
50. Wuthrich R.P., Jenkins T.A., Snyder T.L. Regulation of cytokine-stimulated vascular cell adhesion molecule-1 expression in renal tubular epithelial cells. Transplantation 1993, 55:172-177.
51. Zaccagni H., Fried J., Cornell J., Padilla P., Brey R.L. Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage. Front. Biosci. 2004, 9:1654-1659.
52. Zameer A., Hoffman S.A. Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice. J. Neuroimmunol. 2003, 142:67-74.